Is Costar Technologies, Inc. (CSTI) a Buy, Sell, or Hold?
OTC : CSTI
Costar Technologies, Inc. — News
$4.97 USD
-$0.01 (-0.2%)
- Volume
- 1.3K
- Average Volume
- 885
- Market Capitalization
- $9.74M
- P/E Ratio
- 45.18
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $5.13
- Year Low
- $2.75
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.76
| Source | Headline |
|---|---|
|
Avis Budget Posts Weak Q2 Results, Joins Fiverr International, Costar Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Wednesday. benzinga.com - 2026-07-29 08:03:16 |
|
ConSynance Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of CSTI-500 for Prader-Willi Syndrome
RENSSELAER, N.Y., June 16, 2026 (GLOBE NEWSWIRE) -- ConSynance Therapeutics, Inc. (“ConSynance”), a clinical-stage biotechnology company developing first-in-class therapies for neurobehavioral symptoms in rare neurodevelopmental disorders, today announced that the first participant has been dosed in its Phase 2a clinical trial of CSTI-500 for Prader-Willi syndrome (PWS), marking a significant clinical development milestone for the program. globenewswire.com - 2026-06-16 08:00:00 |
|
Costar Data Shows Big Six Q1 Office Investment Volumes at Their Highest Since 2018
LONDON--(BUSINESS WIRE)--The Big Six office investments reached an eight-year high in the first quarter of 2026, according to data from CoStar, a global leading provider of online real estate marketplaces, information and analytics in the property markets. Investors spent £485m across Birmingham, Bristol, Edinburgh, Glasgow, Leeds and Manchester in the first quarter of the year, slightly above the five-year average. Manchester led activity for the second consecutive quarter, with volumes exceed. businesswire.com - 2026-05-13 05:02:00 |
